A first-of-its-kind drug for new type 1 diabetes
A diagnosis of type 1 diabetes has always meant the same thing on day one: a lifetime of insulin. A newly approved drug will not…
Year: 2026
The papers you would grab in ten minutes
If you had to leave home in a hurry, could you put your hands on the documents that prove who you are, what you own,…
The famous last words no one wrote down
American patriot Nathan Hale, facing a British noose, declared that he regretted having but one life to lose for his country. Thing is, no one…
Why companies are putting a meter on AI
Uber gave a new artificial intelligence coding tool to about 5,000 engineers last December. The engineers loved it. By April the company had spent its…
The reason the company put rules on AI
If your employer recently limited how much artificial intelligence you can use, the reason probably was not you. It was the slide decks. Leaked audio…
This drone hunts mosquitoes
The world’s newest mosquito assassin just scored its first air-to-air kill. The victim, unfortunately, was an innocent moth. French startup Tornyol released the bug into…
Standing counts, but walking counts more
Getting out of the chair is not quite the same as moving. In studies that interrupted long stretches of sitting in older adults, short bouts…
What actually works on moles
If moles have invaded your yard, you have probably tried repellent sprays, pellets, and those vibrating stakes from the garden center. Here is the hard…
The science prizes for making you laugh, then think
Every September, a few weeks before the Nobel Prizes are announced, a rowdier ceremony hands out awards for research that, in its own words, first…
A gene-editing therapy reaches the youngest sickle cell patients
September is Sickle Cell Awareness Month, and this year it arrives with a milestone: the first gene therapy for the disease has reached young children.…